This inventor holds 3 USPTO granted patents. Top assignees: Glaxosmithkline LLC, Smithkline Beecham Corporation. Active years: 2006-2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006-2011
Title: Innovations of Julie Beth Stimmel
Introduction
Julie Beth Stimmel is an accomplished inventor based in Durham, NC (US). She has made significant contributions to the field of biotechnology, particularly in the development of innovative therapeutic agents. With a total of 3 patents to her name, her work has the potential to impact cancer treatment significantly.
Latest Patents
Stimmel's latest patents include a groundbreaking combination of an anti-EP-CAM antibody with a chemotherapeutic agent. This combination is designed to effectively arrest Ep-CAM antigen-expressing cells in the S or G/M phases of the cell cycle. This innovative approach aims to enhance the efficacy of cancer therapies by targeting specific cancer cells more effectively.
Career Highlights
Throughout her career, Stimmel has worked with notable companies such as GlaxoSmithKline LLC and SmithKline Beecham Corporation. Her experience in these organizations has allowed her to develop and refine her innovative ideas, contributing to advancements in medical treatments.
Collaborations
Stimmel has collaborated with esteemed colleagues, including Vincent C. Knick and Linda M. Thurmond. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of biotechnology.
Conclusion
Julie Beth Stimmel's contributions to the field of biotechnology through her patents and collaborations highlight her role as a significant innovator. Her work continues to pave the way for advancements in cancer treatment and therapeutic development.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile